Sanctuary Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Sanctuary Advisors's BMY Position: Q2 2026 in Review
Sanctuary Advisors increased its Bristol-Myers Squibb (BMY) stake by 7.1% in Q2 2026, buying an estimated $1.47M and bringing the position to 384,190 shares worth $22.1M. The position accounts for 0.1% of the portfolio, ranked #212.
Sanctuary Advisors first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Sanctuary Advisors held 384,190 shares of Bristol-Myers Squibb worth $22.1M as of Q2 2026.
- Sanctuary Advisors bought 25,619 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.47M.
- Bristol-Myers Squibb made up 0.1% of Sanctuary Advisors's portfolio in Q2 2026, its #212 holding.
- Sanctuary Advisors first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.